DOI: 10.1016/j. clinical isolates of key Gram-negative and Gram-positive bacteria were collected in 2012 from hospitalised patients in medical centres in four European countries (France, Germany, Italy and Spain) and were tested using standard broth microdilution methodology to assess the impact of 4mg/L avibactam on the in vitro activities of ceftazidime, ceftaroline and aztreonam. A combination of NAC and ciprofloxacin produced a statistically significant.
in vitro spectrophotometry, colony-forming unit and microscopy assays, three antioxidants (N-acetylcysteine, glutathione and vitamin C) and three antibiotics (ciprofloxacin, ceftazidime and tobramycin) were screened and assessed for their ability to disrupt the early and mature biofilms of six B. 106372 ISSN: 0924-8579 Subject: tobramycin, etc Burkholderia cenocepacia acetylcysteine ascorbic acid bicarbonates biofilm ceftazidime chlorides ciprofloxacin cystic fibrosis glutathione growth retardation lungs microscopy morbidity mortality mucus pH pneumonia spectroscopy therapeutics toxicity Show all 22 Subjects Abstract. Glasbey Jim Manos Theerthankar Das Source: International journal of antimicrobial agents 2021 v.58 no.2 pp. DOI: 10.1016/j.ijantimicag.2021.106344Īuthor: Aditi Aiyer Arthika Manoharan Denis Paino Jessica Farrell Gregory S. High quality was documented for 65% and 53. pneumoniae and for imipenem/amikacin or imipenem/ tobramycin against P. Compared with monotherapy, increased bactericidal activity and lower re-growth rates were reported for colistin/fosfomycin and polymyxin/rifampicin in K. 106344 ISSN: 0924-8579 Subject: tobramycin, etc Acinetobacter baumannii Klebsiella pneumoniae Pseudomonas aeruginosa amikacin antibacterial properties ceftazidime colistin confidence interval fosfomycin imipenem meta-analysis pharmacodynamics pharmacokinetics rifampicin synergism systematic review therapeutics Show all 18 Subjects Abstract. Piddock François Franceschi Sally Ellis Elena Carrara Alessia Savoldi Evelina Tacconelli Source: International journal of antimicrobial agents 2021 v.57 no.5 pp.
Giske Thomas Lodise Maurizio Sanguinetti Laura J.V. DOI: 10.1007/s00253-0Īuthor: Luigia Scudeller Elda Righi Margherita Chiamenti Damiano Bragantini Giulia Menchinelli Paolo Cattaneo Christian G. In addition, DCA and MCA also inhibited biofilm formation and enhanced the susceptibility of biofilms to tobramycin, which was evidenced by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). time polymerase chain reaction (qRT-PCR) demonstrated that DCA and MCA markedly suppressed the expression of two QS-related genes (cviI and cviR). 5025-5037 ISSN: 0175-7598 Subject: tobramycin, etc Chromobacterium violaceum Gram-negative bacteria animal pathogens aquatic environment biofilm biotechnology chitinase cinnamic acid ethanolamine hemolysins metabolites metabolomics quantitative polymerase chain reaction soil subtropics violacein virulence Show all 18 Subjects Abstract. DOI: 10.1016/j.ijantimicag.2020.106232Īuthor: Wei-Jia Cheng Jin-Wei Zhou Ping-Ping Zhang Huai-Zhi Luo Shi Tang Jun-Jian Li Shi-Ming Deng Ai-Qun Jia Source: Applied microbiology and biotechnology 2020 v.104 no.11 pp. Although adequate pulmonary biodistribution is important for antibiotic effect, there is a lack of data for both intravenous (IV) and nebulized antibiotic administration during mechanical ventilation.To describe the comparative pulmonary regional distribution of IV and nebulized technetium-99m-labeled tobramycin. Ventilator-associated pneumonia is common and is treated using nebulized antibiotics. 106232 ISSN: 0924-8579 Subject: tobramycin, etc animal models antibacterial properties atomization blood blood sampling cameras computed tomography intravenous injection kidneys liver lungs observational studies pneumonia radiolabeling sheep urine Show all 17 Subjects Abstract. Roberts Source: International journal of antimicrobial agents 2021 v.57 no.2 pp. Fraser Adrian Barnett Sara Diab Manoj Bhatt Jason A. Dhanani Steven Goodman Benjamin Ahern Jeremy Cohen John F.